 Keynote Speech Day 1
Phage Therapy: A New Era of “Old” Concept for “Microbiome” Health
Mzia Kutateladze, Eliava Institute of Bacteriophage, Georgia |
 Keynote Speech Day 2
The Mystery of the Microbiome Genome: The Potential of 2 to 20 Million Microbial Genes to Transform Our Health
Marvin Edeas, Institut Cochin, INSERM U1016, Université de Paris, France |
 Drug Effects of Gut Microbiota in Humans: Clinical Consequences
Carmelo Scarpignato, Chinese University of Hong Kong, China |
 Does the Microbiome Control Cravings and Addictive Behavior of their Host: A New Prospective and Hope for Treating Addiction
Steven R. Gundry, The Centers for Restorative Medicine, USA |
 Mythbusting Our Microbiome
Alan Walker, University of Aberdeen, United Kingdom
|
 Probiotics & Health: How to Select the Right Strain?
Andreas Schwiertz, Institute of Microecology, Germany |
 Gut Brain Axis & Depression: Startegic Role of Dietary Proline Exposed
José Manuel Fernández-Real, Institut d'Investigació Biomèdica de Girona, Hospital Trueta de Girona, and University of Girona, Spain |
 The Small Intestinal Microbiota: A Hidden Player in Human Health and Disease
Pascale Vonaesch, University of Lausanne, Switzerland |
 Microbiota-Derived Extracellular Vesicles: Bridging Mother and Fetus
Justus Reunanen, University of Oulu, Finland
|
 Deciphering the role of the Oral-Placental and Vaginal-Placental Microbiome Axes in Preterm Birth
Souhaila Al Khodor, Sidra Medicine, Qatar |
 Male Fertility and Gut Microbiota: Current Knowledge and Future Directions
Cristian O'Flaherty, McGill University, Canada |
 Gut Microbiome, Obesity and Diabetes
Hiroshi Ohno, RIKEN Center for Integrative Medical Sciences, Japan |
 Microbial Phenotypes in Obesity: Implications for Precision Nutrition
Ellen Blaak, Maastricht University, Netherlands |
 Bacteriophages Redesigned – Tiny Killers and Detectives to Support Infectious Disease Therapy
Martin Loessner, ETH Zurich, Switzerland |
 Prospects for Leveraging the Microbiota as Medicine for Hypertension
Bina Joe, University of Toledo, USA |
 Using Roseoflavin, a Natural Riboflavin Analogue, to Modify the Human Microbiota
Markus Egert, Furtwangen University, Germany
|
 Culturing the Complexity of Intestinal Microbiota In-Vitro in Bac3Gel
Daniela Pacheco, CTO & Founder of Bac3Gel, Portugal |
 Sophisticated in vitro Models of the Gastrointestinal Tract to Study the Role of the Gut Microbiota in Health and Disease
Koen Venema, Editor-in-chief of Beneficial Microbes, Netherlands |
 Gut Microbiota in Early Life: Impact on Neurodevelopmental Outcomes
Rochellys Diaz Heijtz, Karolinska Institutet, Sweden |
 Gut Bacteria and Heart Healing: The Hidden Players in Post-Infarction Resilience
Patrick C. H. Hsieh, Academia Sinica, Tawian |
 Gut Microbiome Signatures in Irritable Bowel Syndrome
Simone Domenico Guglielmetti, Università degli Studi di Milano-Bicocca, Italy |
 From Microbiomes and (Meta)genomes to the Lab and Back - Identification, Production and Application of Bacteriocins
Christian Riedel, University of Ulm, Germany |
